PARNAX LAB LTD. Share Price

PARNAX LAB LTD. Share Price

NSE: PARNAXLAB
|
Pharmaceuticals

₹ 110.26

+₹1.37 (1.26%)
1D
Last updated 13 Oct, 2026, 14:36 IST

PARNAX LAB LTD. Share Price Today

As of 13 Oct 2026, PARNAX LAB LTD. share price is ₹110.26. The stock opened at ₹108.02, compared to its previous close of ₹108.89. During today's trading session, PARNAX LAB LTD. share price moved in the range of ₹106.20 to ₹114.95, with an average price of ₹110.58 for the day. Looking at its last 52-week, the stock has touched a low of ₹104.00 and a high of ₹149.50. On the performance front, PARNAX LAB LTD. share price has declined by 19.66% over the last six months and is down 19.66% on a year-on-year basis.

₹106.20
1.26% up today
₹114.95
1D LOW
1D HIGH

PARNAX LAB LTD. Returns Calculator

Volume
1,727
Average traded price
₹111.28
Last traded time
02:36:49 13 Oct
Last traded quantity
1
Circuit
L
H
₹87.12
₹130.66
52-week
L
H
₹104.00
₹149.50
Mkt Cap Cr
126.80
P/E
14.17
P/B
1.33
ROA
3.93%
ROE
12.38%
ROCE
12.15%
Quick Ratio
0.57
EV/EBITDA
8.03
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Parnax Lab has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Parnax Lab appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Parnax Lab earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,22,067.0134.835.0511.19%13.74%17.33%2.3121.42
Divis Laboratories2,48,982.9885.1214.8514.6%15.32%19.56%3.556.28
Torrent Pharmaceuticals1,77,251.4282.5521.164.87%25.49%13.85%0.7538.11
Zydus Lifesciences1,13,615.6924.744.198.57%18.59%17.35%0.9114.87
Laurus Labs1,11,898.66102.6321.1110.38%16.77%16.14%0.6853.86
Cipla1,06,129.9631.623.087.92%11.27%14.95%2.517.83
Dr. Reddy's Laboratories1,02,707.4132.262.75.48%11.07%12.54%1.3515.86
Mankind Pharma99,089.5247.926.087.36%11.74%13.13%0.7425.7
Aurobindo Pharma97,972.4726.42.596.34%9.25%11.76%1.1512.47
Lupin89,628.8316.033.9614.47%23.76%24.88%1.429.56

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About PARNAX LAB LTD.

PARNAX LAB LTD. Share Price
ISIN
INE383L01019
Sector Market Cap
₹ 126.80 Cr

Parnax Lab Limited is an India-based holding company. The Company is principally engaged in the business activities of manufacturing and export of pharmaceutical formulations. The Company operates through the trading of the pharmaceuticals and medicinal products segment. It is engaged in developing and delivering huge volumes of oral formulations, such as cough expectorants, antacids, antihistamines, multi-vitamins, enzyme preparations, pediatric formulations, special formulations for geriatrics, viscous products, suspensions, and others. Its product portfolio consists of pharmaceuticals, cosmetics, herbal, and nutraceuticals. Its cosmetics products include antidruf gel, EVE fairness acne care night cream for acne skin, EVE fairness scrub, and others. The Company provides companies with the service of developing the drug through Contract Research and Manufacturing Services (C.R.A.M.S) or manufacturing collaborations. The Company’s subsidiary is Naxpar Pharma Private Limited.

PARNAX LAB LTD. Financial Highlights

  • Revenue: PARNAX LAB LTD. reported revenue of ₹252.32 crore in FY26 vs ₹189.42 crore in FY25. It showed an increase of 33.21% on a yearly basis.
  • Operating Profit: PARNAX LAB LTD. reported an operating profit of ₹15.91 crore in FY26 vs ₹15.67 crore in FY25. It showed an increase of 1.53% on a year-on-year basis.
  • Net Profit: PARNAX LAB LTD. reported a net profit of ₹11.80 crore in FY26 vs ₹11.54 crore in FY25. It showed an increase of 2.25% on a yearly basis.

PARNAX LAB LTD. Quarterly Result Highlights

  • PARNAX LAB LTD. reported revenue of ₹56.95 crore in Jun 2026, compared with ₹71.62 crore in Mar 2026, representing a decrease of 20.48% on a quarter-on-quarter (QoQ) basis.
  • PARNAX LAB LTD. reported an operating profit of ₹0.60 crore in Jun 2026, compared with ₹3.00 crore in Mar 2026, representing a decrease of 80.00% on a quarter-on-quarter (QoQ) basis.
  • PARNAX LAB LTD. reported a profit of ₹0.43 crore in Jun 2026, compared with ₹2.18 crore in Mar 2026, reflecting a decrease of 80.28% on a QoQ basis.
  • The earnings per share (EPS) of PARNAX LAB LTD. stood at ₹10.27 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
72.30%
FII
0.00%
Other DII
0.00%
Retail and other
27.70%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
1 day
-5.44%
1 week
-3.83%
1 month
-14.26%
1 year
-19.66%
3 years
-19.66%
5 years
-19.66%
Day
Open / Close
Change %
12 Oct 26
₹115.30 / ₹108.89
-5.44%
09 Oct 26
₹113.64 / ₹115.16
+1.85%
08 Oct 26
₹113.79 / ₹113.07
+1.37%
07 Oct 26
₹111.00 / ₹111.54
-3.29%
Show more

PARNAX LAB LTD. Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹248.54₹187.74₹188.71₹167.61
Other Income₹3.78₹1.68₹0.82₹0.77
Total Revenue₹252.33₹189.41₹189.53₹168.38
Total Expenses₹235.05₹173.74₹177.48₹156.10
Profit Before Tax₹15.91₹15.67₹12.05₹12.28
Tax₹4.11₹4.14₹2.42₹3.65
Profit After Tax₹11.80₹11.54₹9.62₹8.63
EPS - Basic₹10.27₹10.05₹8.37₹7.80
EPS - Diluted₹10.27₹10.05₹8.37₹7.80

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹15.91₹15.67₹12.05₹12.28
Income before WC changes₹30.47₹28.51₹23.91₹23.86
Change in Assets-₹31.10₹8.14-₹13.07₹9.27
Change in Liabilities₹12.14-₹1.61₹7.67-₹9.35
Change in WC-₹18.95₹6.53-₹5.40-₹0.09
Cash flow from Operations₹8.00₹32.30₹15.88₹20.91
Cash flow from Investing-₹16.39-₹16.39-₹31.52-₹9.92
Cash flow from Financing₹8.18-₹15.82₹14.82-₹14.07
Total Cash Flow-₹0.21₹0.09-₹0.82-₹3.08
Cash (Start of the year)₹0.55₹0.46₹1.28₹4.36
Cash (End of the year)₹0.34₹0.55₹0.46₹1.28

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹136.94₹125.04₹116.95₹87.75
Current Assets₹90.69₹64.78₹73.31₹57.32
Total Assets₹227.63₹189.82₹190.26₹145.07
Current Liabilities₹95.85₹74.33₹83.33₹63.04
Net Current Asset-₹5.16-₹9.56-₹10.02-₹5.72
Non-Current Liabilities₹36.48₹32.24₹35.24₹19.77
Equity Capital₹95.30₹83.24₹71.69₹62.26
Total Equity & Liabilities₹227.63₹189.82₹190.26₹145.07

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹6.63₹7.02₹7.44₹7.47
Other Income₹2.37₹0.71₹0.54₹0.37
Total Revenue₹8.99₹7.73₹7.98₹7.84
Total Expenses₹8.31₹5.87₹5.53₹6.22
Profit Before Tax₹0.65₹1.86₹2.45₹1.63
Tax-₹0.24₹0.46₹0.62₹0.42
Profit After Tax₹0.89₹1.39₹1.82₹1.20
EPS - Basic₹0.77₹1.21₹1.59₹1.09
EPS - Diluted₹0.77₹1.21₹1.59₹1.09

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹0.65₹1.86₹2.45₹1.63
Income before WC changes₹1.35₹1.44₹2.34₹1.80
Change in Assets-₹1.30-₹1.81-₹2.35-₹1.34
Change in Liabilities-₹0.76₹0.68₹0.11-₹0.73
Change in WC-₹2.06-₹1.14-₹2.24-₹2.07
Cash flow from Operations-₹0.72₹0.28₹0.08-₹0.28
Cash flow from Investing₹0.57-₹0.19₹0.30₹0.14
Cash flow from Financing-₹0.03-₹0.02-₹1.21-₹2.92
Total Cash Flow-₹0.18₹0.06-₹0.83-₹3.07
Cash (Start of the year)₹0.50₹0.44₹1.27₹4.33
Cash (End of the year)₹0.32₹0.50₹0.44₹1.27

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹12.78₹14.02₹14.20₹14.87
Current Assets₹11.82₹10.69₹8.04₹6.50
Total Assets₹24.60₹24.72₹22.24₹21.37
Current Liabilities₹1.00₹1.74₹1.06₹1.84
Net Current Asset₹10.83₹8.96₹6.98₹4.65
Non-Current Liabilities₹0.19₹0.43₹0.02₹0.17
Equity Capital₹23.42₹22.54₹21.15₹19.35
Total Equity & Liabilities₹24.60₹24.72₹22.24₹21.37
* All values are in INR Crore
Qty
Bid
1
110.26
8
110.25
5
110.04
12
110.03
3
110.02
Ask
Qty
113.5
2
113.7
5
113.8
254
114.55
200
114.9
1
Bid Total: 29
Ask Total: 462
Buy orders: 6%
Sell orders: 94%
Bearish
2
Neutral
6
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
36.73
Neutral
ATR (14)
8.86
Neutral
STOCH(9,6)
56.9
Neutral
STOCH RSI (14)
47.21
Neutral
ADX(9)
22.31
Bearish
UO(9)
42.4
Neutral
ROC(12)
-12.22
Bearish
WillR(14)
-77.01
Neutral
Period
Simple value
Exponential vaue
5D
113.62
113.67
10D
113.24
114.93
20D
118.7
117.18
50D
123.37
0
100D
123.37
0
Volume trend — traded volume by day
13 Oct0L
12 Oct0L
9 Oct0L
8 Oct0L
7 Oct0L
6 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
PARNAX LAB LTD. Share Price
PARNAX LAB LTD.
Pharmaceuticals
Add Stock
Add Another

PARNAX LAB LTD. Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.